Trial
NCT04563559
PREFERENTIAL Study
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Duke University
Collaborators
Ocular Therapeutix, Inc.
Condition
Cataract Surgery
Intervention
Dextenza 0.4Mg Ophthalmic Insert
Why stopped
PI decided not to open study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-11-17